查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1136906

全球颅内支架市场-2022-2029

Global Intracranial Stents Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

全球颅内支架市场受到人口快速老龄化、脑动脉瘤和慢性神经系统疾病（如高血压、胆固醇和糖尿病）发病率增加、自膨式支架领域技术进步和支架灵活性的推动。由于性能力的提高。

慢性神经疾病患病率上升推动市场增长

根据脑动脉瘤基金会 (BAF) 的数据，脑动脉瘤每年导致约 500,000 人死亡，并且在女性中更为常见。 BAF 估计动脉瘤在 35-60 岁年龄段更常见，如果一级亲属（例如父母、兄弟姐妹或孩子）患有动脉瘤，则动脉瘤的发病率会增加。患有结缔组织病和多囊肾病等遗传疾病的患者通常也会患上脑动脉瘤。

根据 2020 年 9 月《神经病学前沿》杂誌，美国 IIH 的年度全国发病率为 1.15/100,000。 2020 年 8 月发表在同一期刊上的另一项研究发现，科威特等中东国家的 IIH 发病率相似，但高于西方地区。据估计，每 10 万人中有 2 人。根据《神经病学、神经外科和精神病学杂誌》的报导，中国人对 ICAS 的耐受性可能不如白种人，而且发病年龄更早。它代表了 ICAD 的最晚期阶段，并且是众所周知的短暂性脑缺血发作 (TIA) 和缺血性中风的原因。

预计会阻碍市场增长的并发症风险

颅内支架製造商和医疗保健服务提供商面临严重的预算限制，以及由于支架迁移并发症和术后脑出血风险而导致外科医生接受度低，预计将在预测期内影响市场。被认为会抑制

COVID-19 影响分析

COVID-19 大流行对颅内支架市场产生了负面影响，包括选择性手术减少、供应链中断和运营挑战。例如，Stryker 报告销售额下降 3.6%，净利润下降 23.2%。儘管 Covid 爆发带来了挑战，但该公司通过 2020 年 11 月收购 Wright Medical 显着增强了其开发能力、产品和服务线以及市场影响力。美敦力神经血管净销售额受到缺血性中风产品的稳定增长和出血性中风产品的适度增长的推动。出血性中风主要在 Pipeline Flex 分流系统中继续增长，部分被第四季度由于与大流行相关的手术中断而导致的下降所抵消。

行业分析

全球颅内支架市场是基于波特五力、监管分析、供应链分析和定价分析、报销政策、技术进步、PEST分析等多种行业因素对市场的深入分析。提供。

全球颅内支架市场报告包含大约 45 多个市场数据表、40 多个数字和 180 页。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品类型划分的市场细分
  • 按疾病划分的市场细分
  • 按设计划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 神经系统慢性疾病增加
    • 约束因素
      • 并发症风险
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 自膨式支架
  • 球囊扩张支架
  • 支架辅助线圈栓塞

第八章疾病适应症

  • 脑动脉瘤
  • 颅内狭窄

第 9 章设计

  • 打开单元格
  • 封闭单元格

第 10 章按应用程序

  • 神经型
  • 纸牌
  • 企业
  • Leoplus
  • 翼展

第 11 章，最终用户

  • 医院
  • 门诊手术中心
  • 诊所
  • 其他

第 12 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 13 章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第 14 章公司简介

  • 美敦力公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Penumbra, Inc
  • Stryker Corporation
  • Boston Scientific Corporation Inc
  • Terumo Corporation
  • Cook Medical
  • DePuy Synthes
  • Balt Extrusion S.A
  • MicroPort Scientific Corporation
  • Abbott Laboratories

第 15 章全球颅内支架市场-DataM

简介目录
Product Code: DMMD929

Market Overview

The Intracranial Stents Market was valued US$ 360 million in 2021 and is estimated to reach US$ 702.8 million by 2029, growing at a CAGR of 8.98% during the forecast period (2022-2029).

An intracranial stent is a tubular structure that is placed inside the canal, duct, or blood vessel. They are used for the treatment of intracranial stenosis. Intracranial stenosis is caused by narrowing of the blood vessels or blood clots due to the building up of fats, plaque, and other substances in the blood vessels. This condition causes stroke in the carotid artery in the neck or an intracranial artery.

Market Dynamics

The global intracranial stents market is growing due to the rapid rise in the geriatric population, an increase in the incidence of chronic neurological diseases like brain aneurysm and hypertension, cholesterol, and diabetes, and technical advances in the field of self-expanding stents and improvement in flexibility of the stents.

Rising prevalence of chronic neurological diseases drives the growth of the market

According to the Brain Aneurysm Foundation (BAF), a brain aneurysm causes around 500,000 deaths annually and is more common among women. BAF estimates that aneurysms are predominant in the age group of 35-60 years, and their occurrence increases if a first-degree relative like a parent, sibling, or child has aneurysms. In addition, patients with genetic disorders like connective tissue disorders or polycystic kidney disease usually suffer from cerebral aneurysms.

According to September 2020 in Frontiers in Neurology Journal, the annual national incidence for IIH was 1.15 out of 100,000 in the United States. Also, per another study published in August 2020 in the same journal, the incidence of IIH was similar in Middle Eastern countries, such as Kuwait and other regions, but was higher than in western areas. It was estimated at 2 per 100,000. According to the Journal of Neurology, Neurosurgery and Psychiatry, Chinese were more unsafe to ICAS than Caucasians, with an earlier age of onset. It represents the most advanced stage of ICAD and is a common cause of Transient Ischemic Attack (TIA) and ischemic stroke.

Risks of complications are expected to hamper the market growth

Tight budgetary constraints faced by intracranial stents manufacturers and healthcare service providers and fewer acceptances among surgeons due to the risks of complications regarding the stent movement and bleeding in the brain after surgery are going to restrain the market in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic led to a reduced number of elective surgeries, supply chain hurdles, operational challenges, and other adverse impacts on the market for intracranial stents. Stryker, for example, reported a 3.6% decline in sales while net earnings decreased by 23.2%. Despite the challenges posed by the covid outbreak, the company significantly strengthened its development capabilities, product and service lines, and the market reaches through the acquisition of Wright Medical in November 2020. Medtronic's net neurovascular sales were driven by the constant growth of Ischemic stroke products and modest growth in hemorrhagic stroke products. Hemorrhagic stroke saw continuous growth, mainly with the Pipeline Flex flow diversion system, partly offset by a decline in the fourth quarter owing to procedural suspensions caused by the pandemic.

Industry Analysis

The global intracranial stents market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis and pricing analysis, reimbursement policies, technological advancements, PEST analysis.

Segment Analysis

The self-expanding stents segment is expected to hold the largest market share in global intracranial stents market

The self-expanding stents segment accounts for the highest market due to the increasing geriatric population, incidence of intracranial disorders and launch of innovative products will boost segment growth. For instance, in May 2019, Stryker's Neuroform Atlas stent received premarket approval from the U.S. FDA. It comprises a self-expanding stent intended for use with detachable metal embolization coils. In addition, the APOLLO Intracranial Stent System from MicroPort Scientific Corporation is explicitly intended for improving cerebral artery lumen diameter in patients with atherosclerosis in intracranial vessels. This stent system comprises a balloon-expandable stent. Product advancements and initiatives by market players are expected to drive the market for intracranial stents.

Geographical Analysis

North America region holds the largest market share in the global intracranial stents market

North America was held a dominant position in the global intracranial stents market in 2021. High prevalence of neurological diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare makes North America the largest revenue generator in the market. According to the Centers for Disease Control and Prevention (CDC), neurological disorders such as epilepsy, Alzheimer's, strokes, multiple sclerosis, and migraines are the 5th leading cause of death in the U.S., affecting around 100 million people every year. This large patient pool costs the nation 800 billion annually, including the cost of health care services, medications, and lost productivity.

This large volume of patients with stroke requires intracranial stenting. As per the American Heart Association, in the year 2020, atherosclerotic stenosis was identified as the primary cause of around 700,000 strokes.

Competitive Landscape

The intracranial stents market is highly competitive, owing to big market players in the industry. The key intracranial stents players which are contributing to the growth of the global market include Penumbra, Inc., Medtronic plc, Stryker Corporation, Boston Scientific Corporation Inc., Terumo Corporation, Cook Medical, DePuy Synthes, Balt Extrusion S.A., MicroPort Scientific Corporation, and Abbott Laboratories among others. The major players are adopting new product development and expansion strategies for global growth in the intracranial stents market. In March 2020, In India, Sree Chitra Tirunal Institute for Medical Sciences and Technology, developed an intracranial flow diverter stent for treating brain aneurysms.

Global Intracranial Stents Market - Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: Pipeline Flex embolization device is the device indicated for the endovascular treatment of adults (22 years of age or older) with certain wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.

The global intracranial stents market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Disease Indication
  • 3.3. Market Snippet by Design
  • 3.4. Market Snippet by Uses
  • 3.5. Market Snippet by End-User
  • 3.6. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising prevalence of chronic neurological diseases
    • 4.1.2. Restraint
      • 4.1.2.1. Risks of complications
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. PEST Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Self-expanding stents*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Balloon expanding stents
  • 7.4. Stent-assisted coil embolization

8. By Disease Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication Segment
    • 8.1.2. Market Attractiveness Index, By Disease Indication Segment
  • 8.2. Brain aneurysm*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Intracranial stenosis

9. By Design

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design Segment
    • 9.1.2. Market Attractiveness Index, By Design Segment
  • 9.2. Open-cell
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Closed-cell

10. By Uses

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses Segment
    • 10.1.2. Market Attractiveness Index, By Uses Segment
  • 10.2. Neuroform*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Solitaire
  • 10.4. Enterprise
  • 10.5. Leo Plus
  • 10.6. Wingspan

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 11.1.2. Market Attractiveness Index, By End User Segment
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Clinics
  • 11.5. Others

12. By Region

  • 12.1. Introduction
  • 12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 12.3. Market Attractiveness Index, By Region
  • 12.4. North America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. US.
      • 12.4.8.2. Canada
      • 12.4.8.3. Mexico
  • 12.5. Europe
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. Germany
      • 12.5.8.2. U.K.
      • 12.5.8.3. France
      • 12.5.8.4. Italy
      • 12.5.8.5. Spain
      • 12.5.8.6. Rest of Europe
  • 12.6. South America
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.6.8.1. Brazil
      • 12.6.8.2. Argentina
      • 12.6.8.3. Rest of South America
  • 12.7. Asia Pacific
    • 12.7.1. Introduction
    • 12.7.2. Key Region-Specific Dynamics
    • 12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.7.8.1. China
      • 12.7.8.2. India
      • 12.7.8.3. Japan
      • 12.7.8.4. Australia
      • 12.7.8.5. Rest of Asia Pacific
  • 12.8. Middle East and Africa
    • 12.8.1. Introduction
    • 12.8.2. Key Region-Specific Dynamics
    • 12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
    • 12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
    • 12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Medtronic plc
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Penumbra, Inc
  • 14.3. Stryker Corporation
  • 14.4. Boston Scientific Corporation Inc
  • 14.5. Terumo Corporation
  • 14.6. Cook Medical
  • 14.7. DePuy Synthes
  • 14.8. Balt Extrusion S.A
  • 14.9. MicroPort Scientific Corporation
  • 14.10. Abbott Laboratories

LIST NOT EXHAUSTIVE

15. Global Intracranial Stents Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us